January 5, 2018 09:27 AM ESTUpdated May 26, 08:50 PM

J&J does Alzheimer's gene therapy deal, along with 14 other new collaborations

Brittany Meiling

Johnson & Johnson has inked a research deal with University of Pennsylvania to work on gene therapy for Alzheimer’s. The partnership leverages the university’s adeno …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

J&J does Alzheimer's gene therapy deal, along with 14 other new collaborations

Brittany Meiling

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

J&J does Alzheimer's gene ther­a­py deal, along with 14 oth­er new col­lab­o­ra­tions

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

J&J does Alzheimer's gene therapy deal, along with 14 other new collaborations